FindTrial
Sign In

A first-in-human study to assess the feasibility and safety of percutaneous transluminal coronary radio frequency for treatment of coronary artery perforation

A first-in-human study to assess the feasibility and safety of percutaneous transluminal coronary radio frequency for treatment of coronary artery perforation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066127
Enrollment
Unknown
Registered
2022-11-24
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery perforation

Interventions

Treatment group:percutaneous transluminal coronary radio frequency

Sponsors

Guizhou Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study includes patients with coronary artery perforation and signing the informed consent.

Exclusion criteria

Exclusion criteria: We exclude patients rejecting the informed consent.

Design outcomes

Primary

MeasureTime frame
Immediate success rate;Clinical success rate;—

Countries

China

Contacts

Public ContactQiang Wu

Guizhou Provincial People's Hospital

654902980@qq.com+86 158 8226 3961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026